Quoin Pharmaceuticals (QNRX) stock: insider trades, news & valuation
Health Care · Strong buyingShare price and insider trades
Quoin Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 5 insiders bought $409K and 0 sold $0 of QNRX stock on the open market, including a cluster buy that began Aug 31, 2026.
Get emailed when insiders cluster-buy stocks like QNRX
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
QNRX insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $280K | 4 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $129K | 1 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 5 Quoin Pharmaceuticals Ltd. insiders reported open-market purchases totaling $409K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Aug 31, 2026, when 4 insiders bought a combined $280K.
QNRX stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
- 8-K Investor disclosure, Other material event
- 8-K Investor disclosure, Other material event
- 8-K Material agreement, Item 3.02, Investor disclosure, Other material event
- 8-K Executive or board change, Shareholder vote results, Other material event
- 8-K Earnings release
- 8-K Investor disclosure, Other material event
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 1SEC | Michael MyersCEO | Buy | 20,49037,713 held (+119%) | $4.88 | $100K | -7.8% | — |
| Sep 1SEC | Denise P. CarterCOO | Buy | 20,49037,709 held (+119%) | $4.88 | $100K | -7.8% | — |
| Sep 1SEC | Sally Bridget LawlorCFO | Buy | 10,24410,684 held (+2328%) | $4.88 | $50K | -7.8% | — |
| Sep 1SEC | Anthony James CulverwellDirector | Buy | 6,14640,364 held (+18%) | $4.88 | $30K | -7.8% | — |
| Oct 15SEC | Dennis LangerDirector | Buy | 15,15215,153 held (+1515200%) | $8.49 | $129K | -47.0% | — |
Insiders at Quoin Pharmaceuticals Ltd.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Dennis LangerDirector | $129K | — | Oct 15, 2025 | — |
| Michael MyersCEO | $100K | — | Sep 1, 2026 | — |
| Denise P. CarterCOO | $100K | — | Sep 1, 2026 | — |
| Sally Bridget LawlorCFO | $50K | — | Sep 1, 2026 | — |
| Anthony James CulverwellDirector | $30K | — | Sep 1, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
QNRX stock: common questions
Are Quoin Pharmaceuticals Ltd. insiders buying QNRX stock?
In the past 12 months, 5 insiders reported open-market purchases of QNRX worth $409K. The latest was CEO Michael Myers bought $100K of QNRX at $4.88 — first open-market purchase in our records; raises the stake by 119%.
Are Quoin Pharmaceuticals Ltd. insiders selling QNRX stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is QNRX's 52-week range?
Over the past year QNRX has traded between $3.25 and $22.30. It last closed at $4.50 on Oct 9, 2026.